Natera's integration into OncoEMR enhances workflow efficiency, simplifying the ordering process for precision medicine tests in oncology practices. The integration supports timely treatment decisions ...
Cross-ancestry polygenic risk score now offered with the Empower™ hereditary cancer test AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global leader in cell-free DNA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results